Skip to main content
. 2013 Jul;81(7):2278–2287. doi: 10.1128/IAI.00497-12

Fig 2.

Fig 2

(A) Increase in arachidonic acid release from T. cruzi (MOI, 0.2)-infected cardiac myocytes in the presence or absence of pretreatment with (R)- or (S)-BEL (2 μM; 10 min). **, P < 0.01 compared to unstimulated release, and ++, P < 0.01 when comparing results for T. cruzi-infected myocytes in the presence or absence of BEL. The values shown are means ± SEM for 4 separate cell cultures. (B) Increase in arachidonic acid release from thrombin-stimulated (0.1 IU/ml) mouse cardiac myocytes with or without pretreatment (10 min) with (R)- or (S)-BEL (2 μM). **, P < 0.01 compared to unstimulated release, and ++, P < 0.01 when comparing results for thrombin-stimulated myocytes in the presence or absence of (R)-BEL. The values shown are means ± SEM for 4 separate cell cultures.